LYRA - Lyra Therapeutics GAAP EPS of -$0.40 beats by $0.04 revenue of $0.36M beats by $0.16M November, 08 2022 05:06 PM Lyra Therapeutics Inc. Lyra Therapeutics press release ( NASDAQ: LYRA ): Q3 GAAP EPS of -$0.40 beats by $0.04 . Revenue of $0.36M (+3500.0% Y/Y) beats by $0.16M . For further details see: Lyra Therapeutics GAAP EPS of -$0.40 beats by $0.04, revenue of $0.36M beats by $0.16M